Researchers at Penn State have developed a novel 3D‑printed, stretchable implant designed to treat high blood pressure (hypertension), especially in patients who do not respond to medication. Known as CaroFlex, the device is made from soft, hydrogel-based materials that mimic the mechanical properties of human tissue, allowing it to flex and move naturally with arteries while adhering to them without the need for stitches. This flexibility significantly reduces the risk of damage compared to traditional rigid implants. The device is placed on the carotid artery, where it delivers gentle electrical signals to stimulate baroreceptors—specialized sensors that help regulate blood pressure. By activating the body’s natural blood pressure control mechanism, the implant can lower blood pressure without relying on drugs. Initial testing has shown that the approach effectively reduces hypertension while minimizing tissue damage, highlighting the potential of 3D‑printed, biocompatible bioelectronics as a next-generation solution in medical treatment.